S1PR2 and metabolic dysfunction-associated steatotic liver disease: Mechanisms through which altered bile acid metabolism can contribute to MASLD development include disruption of the intestinal barrier, as well as activation of Farnesoid X receptor (FXR), Takeda G receptor 5 (TGR5), and sphingosine-1 phosphate receptor 2 (S1PR2) [88].